Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib
Condition:   Gastrointestinal Stromal Tumors (GISTs) Intervention:   Drug: Regorafenib Sponsor:   Asan Medical Center Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2016 Category: Research Source Type: clinical trials

Sarcopenia in Patients With Gastrointestinal Stromal Tumours
Condition:   Gastrointestinal Stromal Tumours Intervention:   Other: Computed tomography Sponsor:   CHU de Reims Completed - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2016 Category: Research Source Type: clinical trials